Welltower (WELL) Stock
Major healthcare real estate owner for senior housing. Here's the price, business snapshot, and what's worth knowing about Welltower in August 2026.
Welltower Inc (WELL) is one of the largest healthcare real estate investment trusts (REITs), specialising in senior housing, assisted living, post-acute care and outpatient medical properties. With a market capitalisation of around $117.12 billion, Welltower owns and finances real estate that it typically leases to healthcare operators under long-term contracts, generating recurring rental income. Investors often watch Welltower for demographic tailwinds — an ageing population and rising demand for senior care — alongside its portfolio mix and tenant credit quality. Key considerations include sensitivity to interest rates (which affect REIT valuations and financing costs), regulatory and policy changes in healthcare, and operational risks linked to facility operators. The company has a history of paying dividends, but income and share price can fluctuate. This summary is for general educational purposes only and not personalised financial advice; readers should do their own research or consult a qualified adviser about suitability for their circumstances.
Why It’s Moving
Welltower is holding firm as analysts stay upbeat and push targets higher.
- Analysts remain broadly constructive on Welltower, with consensus ratings clustered around Buy to Moderate Buy and price targets generally above the current share price, signaling continued confidence in the company’s long-term earnings and asset quality.
- The most recent analyst updates in the past week were target increases from major firms, including RBC Capital and BofA, which suggests Wall Street is still leaning positive even after the stock’s recent run.
- The stock is trading near a relatively tight range versus analyst targets, so the move is being driven more by sentiment around healthcare real estate and REIT valuation than by a single company-specific catalyst.
Welltower is holding firm as analysts stay upbeat and push targets higher.
- Analysts remain broadly constructive on Welltower, with consensus ratings clustered around Buy to Moderate Buy and price targets generally above the current share price, signaling continued confidence in the company’s long-term earnings and asset quality.
- The most recent analyst updates in the past week were target increases from major firms, including RBC Capital and BofA, which suggests Wall Street is still leaning positive even after the stock’s recent run.
- The stock is trading near a relatively tight range versus analyst targets, so the move is being driven more by sentiment around healthcare real estate and REIT valuation than by a single company-specific catalyst.
Sixth Month Growth Performance
next-earnings-question
The next earnings date for WELL is expected on October 26, 2026, based on the company’s reporting cadence. This would cover Q3 2026 results. If the company confirms a formal release date, it would likely fall in late October or early November.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Welltower's stock, expecting it to rise toward the target price of $206.06.
Financial Health
Welltower Inc. is performing well with strong revenue and cash flow, indicating good financial stability.
Dividend
Welltower's dividend yield of 1.3% is lower than average, indicating limited income for investors. If you invested $1000 you would be paid $13 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Demographic tailwind
An ageing population supports demand for senior housing and care services, though local regulation and operator performance can affect outcomes.
Interest-rate sensitivity
Welltower’s valuations and financing costs are influenced by interest rates; rising rates can pressure REIT yields and share prices.
Tenant and portfolio mix
Investor focus often centres on tenant credit quality and geographic diversification — strong tenants can stabilise income, yet operational risks remain.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
